We are live on ! Find out more
DXCM icon

DexCom

983 hedge funds and large institutions have $26.1B invested in DexCom in 2026 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 402 increasing their positions, 350 reducing their positions, and 103 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital inflows, than outflows

Capital inflows: $3.52B | Capital outflows: $2.24B

23% more first-time investments, than exits

New positions opened: 127 | Existing positions closed: 103

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

15% more repeat investments, than reductions

Existing positions increased: 402 | Existing positions reduced: 350

3.92% more ownership

Funds ownership: 96.64% → 100.56% (+3.9%)

1% more funds holding

Funds holding: 969 → 983 (+14)

5% less call options, than puts

Call options by funds: $334M | Put options by funds: $351M

Holders
983
Holders Change
+14
Holders Change %
+1.44%
% of All Funds
11.7%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.07%
New
127
Increased
402
Reduced
350
Closed
103
Calls
$334​M
Puts
$351​M
Net Calls
-⁠$16.3​M
Net Calls Change
-⁠$32.5​M

DXCM Hedge Fund Activity: Q2 2026 in Review

983 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2026, worth a combined $26.1B — up 12% from $23.4B a quarter earlier.

Buyers outnumbered sellers: 127 funds opened new DXCM positions and 103 closed out — a net gain of 24 holders — while 402 added to existing stakes and 350 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $288M. The largest seller was JP Morgan Chase, cutting an estimated $178M.

  • 983 institutional investors held DexCom (DXCM) as of Q2 2026, up from 969 in Q1 2026.
  • Funds reported $26.1B of DexCom stock for Q2 2026, up 12% quarter-over-quarter.
  • 127 funds opened new DexCom positions in Q2 2026 and 103 closed out, a net change of +24 holders.
  • The largest DexCom buyer in Q2 2026 was Arrowstreet Capital, an estimated $288M added.
  • The largest DexCom seller in Q2 2026 was JP Morgan Chase, an estimated $178M sold.

Based on aggregated 13F filings for Q2 2026.